Showing results (11-20 of 85) with videos related to

Sort By:
Pageof 9
Value in Health Regional Issues|March 24, 2026
Vignette-Based Estimation of Utilities in Patients With Metastatic Triple-Negative Breast Cancer in JapanMao Yamaguchi, Kensuke Moriwaki, Tsuguo Iwatani, et al.
Clinical Drug Investigation|June 8, 2022
Cost-Effectiveness of First-Line Nivolumab Plus Ipilimumab Combination Therapy in Advanced Non-Small-Cell Lung Cancer in JapanXiuting Mo, Kensuke Moriwaki, Kosuke Morimoto, et al.
Value in Health Regional Issues|November 20, 2021
Cost-Effectiveness of Nab-Paclitaxel and Gemcitabine Versus Gemcitabine Monotherapy for Patients with Unresectable Metastatic Pancreatic Cancer in JapanKosuke Morimoto, Kensuke Moriwaki, Takako Kaneyasu, et al.
Breast Cancer (Tokyo, Japan)|January 25, 2007
Recent topics of health outcomes research in oncologyKojiro Shimozuma, Hirohisa Imai, Katsumasa Kuroi, et al.
Breast Cancer Research and Treatment|July 31, 2007
The model-based cost-effectiveness analysis of 1-year adjuvant trastuzumab treatment: based on 2-year follow-up HERA trial dataTakeru Shiroiwa, Takashi Fukuda, Kojiro Shimozuma, et al.
Breast Cancer (Tokyo, Japan)|January 25, 2007
Economic evaluation of the prevention and treatment of breast cancer--present status and open issuesHirohisa Imai, Katsumasa Kuroi, Shozo Ohsumi, et al.
Breast Cancer (Tokyo, Japan)|September 17, 2009
Comprehensive geriatric assessment in elderly breast cancer patientsNaruto Taira, Masataka Sawaki, Miyako Takahashi, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 22, 2012
Cost-effectiveness of adjuvant FOLFOX therapy for stage III colon cancer in Japan based on the MOSAIC trialTakeru Shiroiwa, Toshihiro Takeuchi, Takashi Fukuda, et al.
Pharmacoeconomics|August 12, 2009
Cost-effectiveness analysis of capecitabine compared with bolus 5-fluorouracil/l-leucovorin for the adjuvant treatment of colon cancer in JapanTakeru Shiroiwa, Takashi Fukuda, Kojiro Shimozuma, et al.
Breast Cancer (Tokyo, Japan)|January 25, 2007
Current status of health outcome assessment of medical treatment in breast cancerKatsumasa Kuroi, Kojiro Shimozuma, Shozo Ohsumi, et al.
Pageof 9